Judge Rules For Glaxo In Zofran Patent Case
A federal judge in New Jersey has issued a summary judgment ruling that a subsidiary of Par Pharmaceuticals infringed GlaxoSmithKline's patents for anti-nausea treatment Zofran when it filed an application to...To view the full article, register now.
Already a subscriber? Click here to view full article